Akero Therapeutics Inc sell dimontalban
Start price
13:45
/
70%
€46.60
Target price
13.10.26
€25.00
Performance (%)
0.00%
Price
15:57
€46.60
Summary
This prediction is currently active. dimontalban's SELL prediction for Akero Therapeutics Inc is currently unchanged. This prediction currently runs until 13.10.26. The prediction end date can be changed by dimontalban at any time. dimontalban has 70% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Akero Therapeutics Inc | 0.00% |
| iShares Core DAX® | -0.693% |
| iShares Nasdaq 100 | -1.173% |
| iShares Nikkei 225® | -1.388% |
| iShares S&P 500 | -1.411% |
According to dimontalban what are the pros and cons of Akero Therapeutics Inc for the foreseeable future?
Pros
Differentiated customer and product portfolio
Sustainability is important
Stable Large shareholder and/or long term investor
Revenue growth >5% per year expected
Good rating
Standard Investments for future growth
Top 10 in its market
Known brand
Future proof or reliable business model
Cons
High valuation
High risks in the balance sheet
Increased challenges to pay loans and raise capital
Significant cyclical dependencies
Probably not worthwhile Investment
Lower EBIT Margin than peer group
EBIT decline/stagnation expected
very negative Cash Flow expected
ROE lower than 10% per year
Below average Management
Little innovation
No uniques
Growths slower than the competition
High risks for its business
Very low/no dividend yield expected
Bad culture
Comments by dimontalban for this prediction
In the thread Akero Therapeutics Inc diskutieren
Sell mit Kursziel 25,0
Stopped prediction by dimontalban for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.40
15.09.22
15.09.22
€11.00
15.09.23
15.09.23
-1.52%
17.09.22
17.09.22
Differentiated customer and product portfolio
High valuation
High risks in the balance sheet
Increased challenges to pay loans and raise capital
